Feiyang Qi
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Transcriptome-Inferred metabolic subtypes define prognostic and immune ecosystems in osteosarcoma at single-cell resolution.
Journal: Frontiers in pediatrics
Published: March 16, 2026
Paired single cell analysis reveals chemotherapy resistance in osteosarcoma.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: January 21, 2026
Age-Stratified Transcriptomic Profiling Reveals Biologically Distinct Molecular Phenotypes Across Pediatric, Adolescent, and Adult Osteosarcoma.
Journal: Biomedicines
Published: December 28, 2025
A pan-cancer analysis revealed SKP2 as an inhibitor of the tumor immune microenvironment and a promising therapeutic target for immunotherapy.
Journal: Precision clinical medicine
Published: August 02, 2025
Characterization of Parthanatos in Breast Cancer: Implications for Prognosis and PARP Inhibitor Resistance.
Journal: Bioengineering (Basel, Switzerland)
Published: April 29, 2025
Development of a global forearm reconstruction system for post-tumor resection defects of the radius or ulna: a proof-of-concept study.
Journal: Frontiers in bioengineering and biotechnology
Published: December 18, 2024
External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy.
Journal: Leukemia
Published: April 16, 2023
Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era.
Journal: Annals of hematology
Published: March 20, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026